The Prevalence of Menstrual Cycle Disorders and Menstrual Cycle-Related Symptoms in Female Athletes: A Systematic Literature Review.
Journal
Sports medicine (Auckland, N.Z.)
ISSN: 1179-2035
Titre abrégé: Sports Med
Pays: New Zealand
ID NLM: 8412297
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
accepted:
04
06
2023
medline:
18
9
2023
pubmed:
30
6
2023
entrez:
30
6
2023
Statut:
ppublish
Résumé
Menstrual cycle (MC) disorders and MC-related symptoms can have debilitating effects on the health and performance of female athletes. As the participation of women in sports continues to increase, understanding the prevalence of a range of MC disorders and MC-related symptoms may guide preventive strategies to protect the health and optimise the performance of female athletes. To examine the prevalence of MC disorders and MC-related symptoms among female athletes who are not using hormonal contraceptives and evaluate the assessment methods used to identify MC disorders and MC-related symptoms. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Six databases were searched until September 2022 for all original research that reported the prevalence of MC disorders and/or MC-related symptoms in athletes not using hormonal contraceptives, which included the definitions of the MC disorders examined, and the assessment methods used. MC disorders included amenorrhoea, anovulation, dysmenorrhoea, heavy menstrual bleeding (HMB), luteal phase deficiency (LPD), oligomenorrhoea, premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). MC-related symptoms included any affective and physical symptoms related to the MC that do not cause significant personal, interpersonal or functional impairment. The prevalence data across eligible studies were combined, and all studies were qualitatively synthesised to evaluate the assessment methods and tools used to identify MC disorders and MC-related symptoms. The methodological quality of studies was assessed using a modified Downs and Black checklist. Sixty studies involving 6380 athletes were included. A wide range of prevalence was observed for all types of MC disorders, with a dearth of data on anovulation and LPD. Based on pooled data, dysmenorrhoea (32.3%; range 7.8-85.6%) was the most prevalent MC disorder. Studies reporting MC-related symptoms mostly examined the premenstrual and menstruation phases, where affective symptoms appeared more prevalent than physical symptoms. A larger proportion of athletes reported symptoms during the initial days of menstruation compared with the premenstrual phase. MC disorders and MC-related symptoms were retrospectively assessed using self-report methods in 90.0% of studies. Most studies (76.7%) in this review were graded as moderate quality. MC disorders and MC-related symptoms are commonplace among female athletes, warranting further research examining their impact on performance and preventive/management strategies to optimise athlete health. To increase the quality of future studies, researchers should adopt standardised definitions of MC disorders and assessment methods such as a combination of calendar counting, urinary ovulation tests and a mid-luteal phase serum progesterone measurement when assessing menstrual function. Similarly, standardised diagnostic criteria should be used when examining MC disorders such as HMB, PMS and PMDD. Practically, implementing prospective cycle monitoring that includes ovulation testing, mid-luteal blood sampling (where feasible) and symptom logging throughout the MC could support athletes and practitioners to promptly identify and manage MC disorders and/or MC-related symptoms. This review has been registered in the PROSPERO database (CRD42021268757).
Sections du résumé
BACKGROUND
Menstrual cycle (MC) disorders and MC-related symptoms can have debilitating effects on the health and performance of female athletes. As the participation of women in sports continues to increase, understanding the prevalence of a range of MC disorders and MC-related symptoms may guide preventive strategies to protect the health and optimise the performance of female athletes.
OBJECTIVE
To examine the prevalence of MC disorders and MC-related symptoms among female athletes who are not using hormonal contraceptives and evaluate the assessment methods used to identify MC disorders and MC-related symptoms.
METHODS
This systematic review was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Six databases were searched until September 2022 for all original research that reported the prevalence of MC disorders and/or MC-related symptoms in athletes not using hormonal contraceptives, which included the definitions of the MC disorders examined, and the assessment methods used. MC disorders included amenorrhoea, anovulation, dysmenorrhoea, heavy menstrual bleeding (HMB), luteal phase deficiency (LPD), oligomenorrhoea, premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). MC-related symptoms included any affective and physical symptoms related to the MC that do not cause significant personal, interpersonal or functional impairment. The prevalence data across eligible studies were combined, and all studies were qualitatively synthesised to evaluate the assessment methods and tools used to identify MC disorders and MC-related symptoms. The methodological quality of studies was assessed using a modified Downs and Black checklist.
RESULTS
Sixty studies involving 6380 athletes were included. A wide range of prevalence was observed for all types of MC disorders, with a dearth of data on anovulation and LPD. Based on pooled data, dysmenorrhoea (32.3%; range 7.8-85.6%) was the most prevalent MC disorder. Studies reporting MC-related symptoms mostly examined the premenstrual and menstruation phases, where affective symptoms appeared more prevalent than physical symptoms. A larger proportion of athletes reported symptoms during the initial days of menstruation compared with the premenstrual phase. MC disorders and MC-related symptoms were retrospectively assessed using self-report methods in 90.0% of studies. Most studies (76.7%) in this review were graded as moderate quality.
DISCUSSION
MC disorders and MC-related symptoms are commonplace among female athletes, warranting further research examining their impact on performance and preventive/management strategies to optimise athlete health. To increase the quality of future studies, researchers should adopt standardised definitions of MC disorders and assessment methods such as a combination of calendar counting, urinary ovulation tests and a mid-luteal phase serum progesterone measurement when assessing menstrual function. Similarly, standardised diagnostic criteria should be used when examining MC disorders such as HMB, PMS and PMDD. Practically, implementing prospective cycle monitoring that includes ovulation testing, mid-luteal blood sampling (where feasible) and symptom logging throughout the MC could support athletes and practitioners to promptly identify and manage MC disorders and/or MC-related symptoms.
TRIAL REGISTRATION
This review has been registered in the PROSPERO database (CRD42021268757).
Identifiants
pubmed: 37389782
doi: 10.1007/s40279-023-01871-8
pii: 10.1007/s40279-023-01871-8
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1963-1984Subventions
Organisme : Irish Research Council
ID : GOIPG/2022/2230
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
American College of Obstetricians and Gynecologists. Practice Bulletin No. 128: Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged Women. 2012. https://journals.lww.com/greenjournal/Citation/2012/07000/Practice_Bulletin_No__128__Diagnosis_of_Abnormal.41.aspx . Accessed 1 Nov 2021.
Broekmans FJ, Visser JA, Laven JSE, Broer SL, Themmen APN, Fauser BC. Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340–7.
pubmed: 18805020
doi: 10.1016/j.tem.2008.08.002
Phillips NA, Bachmann G. Premenstrual syndrome and dysphoric disorder - Symptoms, diagnosis and treatment. BMJ Best Practice. 2022. https://bestpractice.bmj.com/topics/en-us/419 . Accessed 10 Nov 2022.
Goldman MB, Hatch MC. Women and Health. Berlin: Elsevier; 1999.
Ellison PT. Human ovarian function and reproductive ecology: new hypotheses. Am Anthropolog. 1990;92:933–52.
doi: 10.1525/aa.1990.92.4.02a00050
Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Res. 2017;6:1645.
pubmed: 28944048
pmcid: 5585876
doi: 10.12688/f1000research.11682.1
Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Phys. 2011;84:918–24.
Manore MM. Dietary recommendations and athletic menstrual dysfunction. Sports Med. 2002;32:887–901.
pubmed: 12427050
doi: 10.2165/00007256-200232140-00002
Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicine position stand. The Female Athlete Triad. Med Sci Sports Exerc. 1997;29:i–ix.
pubmed: 9140913
doi: 10.1097/00005768-199705000-00037
Nattiv A, Loucks AB, Manore MM, Sanborn CF, Sundgot-Borgen J, Warren MP. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc. 2007;39:1867–82.
pubmed: 17909417
Shufelt CL, Torbati T, Dutra E. Hypothalamic amenorrhea and the long-term health consequences. Semin Reprod Med. 2017;35:256–62.
pubmed: 28658709
pmcid: 6374026
doi: 10.1055/s-0037-1603581
De Souza MJ, West SL, Jamal SA, Hawker GA, Gundberg CM, Williams NI. The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone. 2008;43:140–8.
pubmed: 18486582
doi: 10.1016/j.bone.2008.03.013
O’Donnell E, Harvey PJ, Goodman JM, De Souza MJ. Long-term estrogen deficiency lowers regional blood flow, resting systolic blood pressure, and heart rate in exercising premenopausal women. Am J Physiol Endocrinol Metab. 2007;292:E1401-1409.
pubmed: 17227959
doi: 10.1152/ajpendo.00547.2006
Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, Hirschberg AL. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab. 2005;90:1354–9.
pubmed: 15572426
doi: 10.1210/jc.2004-1286
Elliott-Sale KJ, Minahan CL, de Jonge XAKJ, Ackerman KE, Sipilä S, Constantini NW, et al. Methodological considerations for studies in sport and exercise science with women as participants: a working guide for standards of practice for research on women. Sports Med [Internet]. 2021. https://doi.org/10.1007/s40279-021-01435-8 .
doi: 10.1007/s40279-021-01435-8
pubmed: 33725341
Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand. 2014;93:52–7.
pubmed: 24266506
doi: 10.1111/aogs.12292
Gao M, Zhang H, Gao Z, Cheng X, Sun Y, Qiao M, et al. Global and regional prevalence and burden for premenstrual syndrome and premenstrual dysphoric disorder. Medicine (Baltimore). 2022;101: e28528.
pubmed: 35029919
doi: 10.1097/MD.0000000000028528
Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104–13.
pubmed: 24284871
doi: 10.1093/epirev/mxt009
Bruinvels G, Goldsmith E, Blagrove R, Simpkin A, Lewis N, Morton K, et al. Prevalence and frequency of menstrual cycle symptoms are associated with availability to train and compete: a study of 6812 exercising women recruited using the Strava exercise app. Br J Sports Med. 2021;55:438–43.
pubmed: 33199360
doi: 10.1136/bjsports-2020-102792
Armour M, Parry KA, Steel K, Smith CA. Australian female athlete perceptions of the challenges associated with training and competing when menstrual symptoms are present. Int J Sports Sci Coach. 2020;15:316–23.
doi: 10.1177/1747954120916073
Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. J Endocrinol. 2001;170:3–11.
pubmed: 11431132
doi: 10.1677/joe.0.1700003
De Souza MJ, Toombs RJ, Scheid JL, O’Donnell E, West SL, Williams NI. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod. 2010;25:491–503.
pubmed: 19945961
doi: 10.1093/humrep/dep411
Torstveit MK, Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc. 2005;37:1449–59.
pubmed: 16177594
doi: 10.1249/01.mss.0000177678.73041.38
McNulty KL, Elliott-Sale KJ, Dolan E, Swinton PA, Ansdell P, Goodall S, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020;50:1813–27.
pubmed: 32661839
pmcid: 7497427
doi: 10.1007/s40279-020-01319-3
Elliott-Sale KJ, McNulty KL, Ansdell P, Goodall S, Hicks KM, Thomas K, et al. The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis. Sports Med. 2020;50:1785–812.
pubmed: 32666247
pmcid: 7497464
doi: 10.1007/s40279-020-01317-5
Elliott-Sale KJ, Ross E, Burden R, Hicks K. The BASES Expert Statement on conducting and implementing female athlete-based research. Sport Exerc Sci. 2020;65:6–7.
Pitchers G, Elliott-sale K. Considerations for coaches training female athletes. Prof Strength Cond. 2019;55:19–30.
Roupas ND, Georgopoulos NA. Menstrual function in sports. Hormones (Athens). 2011;10:104–16.
pubmed: 21724535
doi: 10.14310/horm.2002.1300
De Souza MJ, Nattiv A, Joy E, Misra M, Williams NI, Mallinson RJ, et al. 2014 Female Athlete Triad Coalition consensus statement on treatment and return to play of the female athlete triad: 1st International Conference held in San Francisco, CA, May 2012, and 2nd International Conference held in Indianapolis, IN, May 2013. Clin J Sport Med. United States; 2014;24:96–119.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89.
pubmed: 33781348
pmcid: 8008539
doi: 10.1186/s13643-021-01626-4
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.
pubmed: 9764259
pmcid: 1756728
doi: 10.1136/jech.52.6.377
McKay AKA, Stellingwerff T, Smith ES, Martin DT, Mujika I, Goosey-Tolfrey VL, et al. Defining Training and performance caliber: a participant classification framework. Int J Sports Physiol Perform. 2022;17:317–31.
pubmed: 34965513
doi: 10.1123/ijspp.2021-0451
Smith ES, McKay AKA, Ackerman KE, Harris R, Elliott-Sale KJ, Stellingwerff T, et al. Methodology review: a protocol to audit the representation of female athletes in sports science and sports medicine research. Int J Sport Nutr Exerc Metab. 2022;1:1–14.
Master-Hunter T, Heiman DL. Amenorrhea: evaluation and treatment. Am Family Phys. 2006;73:1374–82.
Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril. 2008;90:S219-225.
doi: 10.1016/j.fertnstert.2008.08.038
Hackney AC, Smith-Ryan AE, Fink JE. Methodological considerations in exercise endocrinology. In: Hackney AC, Constantini NW, editors. Endocrinology of physical activity and sport [Internet]. Cham: Springer International Publishing; 2020. p. 1–17. https://doi.org/10.1007/978-3-030-33376-8_1 .
doi: 10.1007/978-3-030-33376-8_1
Klein DA, Poth MA. Amenorrhea: an approach to diagnosis and management. AFP. 2013;87:781–8.
Janse DE, Jonge X, Thompson B, Han A. Methodological recommendations for menstrual cycle research in sports and exercise. Med Sci Sports Exerc. 2019;51:2610–7.
doi: 10.1249/MSS.0000000000002073
reVITALize: Gynecology Data Definitions. https://www.acog.org/en/practice-management/health-it-and-clinical-informatics/revitalize-gynecology-data-definitions . Accessed 1 Nov 2021.
ACOG Committee Opinion No. 760: Dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132:e249–58.
doi: 10.1097/AOG.0000000000002978
Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428–41.
pubmed: 16880317
doi: 10.1097/01.AOG.0000230214.26638.0c
Kadian S, O’Brien S. Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders. Menopause Int. 2012;18:43–7.
pubmed: 22611220
doi: 10.1258/mi.2012.012017
Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. AFP. 2003;67:1743–52.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.
doi: 10.1176/appi.books.9780890425596
Lanhers C, Courteix D, Valente-Dos-Santos J, Ferry B, Gracia-Marco L, Pereira B, et al. Gonadal hormones may predict structural bone fragility in elite female soccer player. J Sports Sci. 2020;38:827–37.
pubmed: 32149566
doi: 10.1080/02640414.2020.1735982
Bacchi E, Spiazzi G, Zendrini G, Bonin C, Moghetti P. Low body weight and menstrual dysfunction are common findings in both elite and amateur ballet dancers. J Endocrinol Invest. 2013;36:343–6.
pubmed: 23027765
Barrack MT, Van Loan MD, Rauh MJ, Nichols JF. Physiologic and behavioral indicators of energy deficiency in female adolescent runners with elevated bone turnover. Am J Clin Nutr. 2010;92:652–9.
pubmed: 20610635
doi: 10.3945/ajcn.2009.28926
Beals KA, Manore MM. Disorders of the female athlete triad among collegiate athletes. Int J Sport Nutr Exerc Metab. 2002;12:281–93.
pubmed: 12432173
doi: 10.1123/ijsnem.12.3.281
Brooks-Gunn J, Warren MP, Hamilton LH. The relation of eating problems and amenorrhea in ballet dancers. Med Sci Sports Exerc. 1987;19:41–4.
pubmed: 3469489
doi: 10.1249/00005768-198702000-00009
Calabrese LH, Kirkendall DT, Floyd M, Rapoport S, Williams GW. Menstrual abnormalities, nutritional patterns, and body composition in female classical ballet dancers. Phys Sportsmed. 1983;11:86–90.
pubmed: 27463163
doi: 10.1080/00913847.1983.11708458
Cook SD, Harding AF, Thomas KA, Morgan EL, Schnurpfeil KM, Haddad RJ Jr. Trabecular bone density and menstrual function in women runners. Am J Sports Med. 1987;15:503–7.
pubmed: 3674275
doi: 10.1177/036354658701500514
Czajkowska M, Drosdzol-Cop A, Gałązka I, Naworska B, Skrzypulec-Plinta V. Menstrual cycle and the prevalence of premenstrual syndrome/premenstrual dysphoric disorder in adolescent athletes. J Pediatr Adolesc Gynecol. 2015;28:492–8.
pubmed: 26233292
doi: 10.1016/j.jpag.2015.02.113
Czajkowska M, Plinta R, Rutkowska M, Brzęk A, Skrzypulec-Plinta V, Drosdzol-Cop A. Menstrual cycle disorders in professional female rhythmic gymnasts. Int J Environ Res Public Health. 2019;16:1470.
pubmed: 31027248
pmcid: 6518119
doi: 10.3390/ijerph16081470
Dusek T. Influence of high intensity training on menstrual cycle disorders in athletes. Croat Med J. 2001;42:79–82.
pubmed: 11172662
Egan E, Reilly T, Whyte G, Giacomoni M, Cable NT. Disorders of the menstrual cycle in elite female ice hockey players and figure skaters. Biol Rhythm Res. 2003;34:251–64.
doi: 10.1076/brhm.34.3.251.18806
Fogelholm M, Van Marken LW, Ottenheijm R, Westerterp K. Amenorrhea in ballet dancers in the Netherlands. Med Sci Sports Exerc. 1996;28:545–50.
pubmed: 9148082
Foster R, Vaisberg M, Araújo MP, Martins MA, Capel T, Bachi ALL, et al. Relationship between Anxiety and Interleukin 10 in Female Soccer Players with and Without Premenstrual Syndrome (PMS). Rev Bras Ginecol Obstet. 2017;39:602–7.
pubmed: 28847026
pmcid: 10309485
doi: 10.1055/s-0037-1606244
Frisch RE, Albright T, Gotz-Welbergen AV, Witschi J, McArthur JW. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. J Am Med Assoc. 1981;246:1559–63.
doi: 10.1001/jama.1981.03320140047029
Goodwin Y, Monyeki MA, Boit MK, De Ridder JH, Toriola AL, Mwangi FM, et al. Association between energy availability and menstrual function in elite Kenyan runners. Afr J Phys Health Educ Recreat Dance. 2014;20:291–307.
Guler F, Hascelik Z. Menstrual dysfunction rate and delayed menarche in top athletes of team games. Sports Med Train Rehabil. 1993;4:99–106.
doi: 10.1080/15438629309511972
Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism may explain reproductive dysfunction in olympic athletes. Med Sci Sports Exerc. 2009;41:1241–8.
pubmed: 19461542
doi: 10.1249/MSS.0b013e318195a21a
Hammar ML, Hammar-Henriksson MB, Frisk J, Rickenlund A, Wyon YA. Few oligo-amenorrheic athletes have vasomotor symptoms. Maturitas. 2000;34:219–25.
pubmed: 10717487
doi: 10.1016/S0378-5122(99)00115-2
Harber VJ, Webber CE, Sutton JR, MacDougall JD. The effect of amenorrhea on calcaneal bone density and total bone turnover in runners. Int J Sports Med. 1991;12:505–8.
pubmed: 1752722
doi: 10.1055/s-2007-1024724
Hoch AZ, Pajewski NM, Moraski L, Carrera GF, Wilson CR, Hoffmann RG, et al. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med. 2009;19:421–8.
pubmed: 19741317
pmcid: 2848387
doi: 10.1097/JSM.0b013e3181b8c136
Ihalainen JK, Kettunen O, McGawley K, Solli GS, Hackney AC, Mero AA, et al. Body composition, energy availability, training, and menstrual status in female runners. Int J Sports Physiol Perform. 2021;16:1043–8.
pubmed: 33690163
doi: 10.1123/ijspp.2020-0276
Jenkins PJ, Ibanez-Santos X, Holly J, Cotterill A, Perry L, Wolman R, et al. IGFBP-1: a metabolic signal associated with exercise-induced amenorrhoea. Neuroendocrinology. 1993;57:600–4.
pubmed: 7690116
doi: 10.1159/000126413
Kishali NF, Imamoglu O, Katkat D, Atan T, Akyol P. Effects of menstrual cycle on sports performance. Int J Neurosci. 2006;116:1549–63.
pubmed: 17145688
doi: 10.1080/00207450600675217
Maïmoun L, Coste O, Georgopoulos NA, Roupas ND, Mahadea KK, Tsouka A, et al. Despite a high prevalence of menstrual disorders, bone health is improved at a weight-bearing bone site in world-class female rhythmic gymnasts. J Clin Endocrinol Metab. 2013;98:4961–9.
pubmed: 24106284
doi: 10.1210/jc.2013-2794
Martin D, Sale C, Cooper SB, Elliott-Sale KJ. Period Prevalence and perceived side effects of hormonal contraceptive use and the menstrual cycle in elite athletes. Int J Sports Physiol Perform. 2018;13:926–32.
pubmed: 29283683
doi: 10.1123/ijspp.2017-0330
Melin A, Tornberg ÅB, Skouby S, Møller SS, Sundgot-Borgen J, Faber J, et al. Energy availability and the female athlete triad in elite endurance athletes. Scand J Med Sci Sports. 2015;25:610–22.
pubmed: 24888644
doi: 10.1111/sms.12261
Möller-Nielsen J, Hammar M. Women’s soccer injuries in relation to the menstrual cycle and oral contraceptive use. Med Sci Sports Exerc. 1989;21:126–9.
pubmed: 2709976
Molnár AH, Vidiczki-Dóczi A, Petrovszki Z, Győri F. Prevalence of eating disorders and menstrual irregularities among female football players. Arena J Phys Activ. 2016;5:16–27.
Momma R, Nakata Y, Sawai A, Takeda M, Natsui H, Mukai N, et al. Comparisons of the prevalence, severity, and risk factors of dysmenorrhea between Japanese female athletes and non-athletes in universities. Int J Environ Res Public Health. 2021;19:52.
pubmed: 35010312
pmcid: 8744957
doi: 10.3390/ijerph19010052
Mukherjee P, Mishra SK, Ray S. Menstrual characteristics of adolescent athletes: a study from West Bengal, India. Coll Antropol. 2014;38:917–23.
pubmed: 25420374
Myburgh KH, Berman C, Novick I, Noakes TD, Lambert EV. Decreased Resting Metabolic Rate in Ballet Dancers With Menstrual Irregularity. Int J Sport Nutr. 1999;9:285.
pubmed: 10477364
doi: 10.1123/ijsn.9.3.285
Nichols JF, Rauh MJ, Lawson MJ, Ji M, Barkai HS. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med. 2006;160:137–42.
pubmed: 16461868
doi: 10.1001/archpedi.160.2.137
Nose-Ogura S, Yoshino O, Dohi M, Kigawa M, Harada M, Kawahara T, et al. Low bone mineral density in elite female athletes with a history of secondary amenorrhea in their teens. Clin J Sport Med. 2020;30:245–50.
pubmed: 32341292
Oxfeldt M, Dalgaard LB, Jørgensen AA, Hansen M. Hormonal contraceptive use, menstrual dysfunctions, and self-reported side effects in elite athletes in Denmark. Int J Sports Physiol Perform. 2020;15:1377–84.
pubmed: 32957078
doi: 10.1123/ijspp.2019-0636
Parker LJ, Elliott-Sale KJ, Hannon MP, Morton JP, Close GL. An audit of hormonal contraceptive use in Women’s Super League soccer players; implications on symptomology. Sci Med Footb. 2022;6:153–8.
pubmed: 35475746
doi: 10.1080/24733938.2021.1921248
Pollock N, Grogan C, Perry M, Pedlar C, Cooke K, Morrissey D, et al. Bone-mineral density and other features of the female athlete triad in elite endurance runners: a longitudinal and cross-sectional observational study. Int J Sport Nutr Exerc Metab. 2010;20:418–26.
pubmed: 20975110
doi: 10.1123/ijsnem.20.5.418
Quah YVMS, Poh BKP, Ng LODP, Noor MIP. The female athlete triad among elite Malaysian athletes: prevalence and associated factors. Asia Pac J Clin Nutr. 2009;18:200–8.
pubmed: 19713179
Roberts TA, Glen J, Kreipe RE. Disordered eating and menstrual dysfunction in adolescent female athletes participating in school-sponsored sports. Clin Pediatr. 2003;42:561–4.
doi: 10.1177/000992280304200613
Robinson TL. Bone mineral and menstrual cycle status in competitive female athletes: a longitudinal study. Oregon State University; 1996. https://ir.library.oregonstate.edu/concern/graduate_thesis_or_dissertations/gh93h161c . Accessed 6 Aug 2021.
Rutherford OM. Spine and total body bone mineral density in amenorrheic endurance athletes. J Appl Physiol. 1993;74:2904–8.
pubmed: 8365991
doi: 10.1152/jappl.1993.74.6.2904
Schtscherbyna A, Soares EA, de Oliveira FP, Ribeiro BG. Female athlete triad in elite swimmers of the city of Rio de Janeiro, Brazil. Nutrition. 2009;25:634–9.
pubmed: 19230616
doi: 10.1016/j.nut.2008.11.029
Stefani L, Galanti G, Lorini S, Beni G, Dei M, Maffulli N. Female athletes and menstrual disorders: a pilot study. Muscles Ligaments Tendons J (MLTJ). 2016;6:183–7.
pubmed: 27900290
doi: 10.32098/mltj.02.2016.03
Stokic E, Srdic B, Barak O. Body mass index, body fat mass and the occurrence of amenorrhea in ballet dancers. Gynecol Endocrinol. 2005;20:195–9.
pubmed: 16019361
doi: 10.1080/09513590400027224
Sygo J, Coates AM, Sesbreno E, Mountjoy ML, Burr JF. Prevalence of indicators of low energy availability in elite female sprinters. Int J Sport Nutr Exerc Metab. 2018;28:490–6.
pubmed: 29757049
doi: 10.1123/ijsnem.2017-0397
Takeda T, Imoto Y, Nagasawa H, Muroya M, Shiina M. Premenstrual SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER in Japanese Collegiate Athletes. J Pediatr Adolesc Gynecol. 2015;28:215–8.
pubmed: 26028154
doi: 10.1016/j.jpag.2014.07.006
Takeda T, Imoto Y, Nagasawa H, Takeshita A, Shiina M. Stress fracture and premenstrual syndrome in Japanese adolescent athletes: a cross-sectional study. BMJ Open. 2016;6: e013103.
pubmed: 27798029
pmcid: 5073596
doi: 10.1136/bmjopen-2016-013103
Takeda T, Ueno T, Uchiyama S, Shiina M. Premenstrual symptoms interference and equal production status in Japanese collegiate athletes: a cross-sectional study. J Obstet Gynaecol Res. 2018;44:488–94.
pubmed: 29226551
doi: 10.1111/jog.13552
Thompson SHEC. Characteristics of the Female Athlete Triad in Collegiate Cross-Country Runners. J Am Coll Health. 2007;56:129–36.
pubmed: 17967758
doi: 10.3200/JACH.56.2.129-136
Toriola AL. Survey of menstrual function in young Nigerian athletes. Int J Sports Med. 1988;9:29–34.
pubmed: 3366516
doi: 10.1055/s-2007-1024974
Toriola AL, Mathur DN. Menstrual dysfunction in Nigerian athletes. Br J Obstet Gynaecol. 1986;93:979–85.
pubmed: 3768291
doi: 10.1111/j.1471-0528.1986.tb08020.x
Tsukahara Y, Torii S, Yamasawa F, Iwamoto J, Otsuka T, Goto H, et al. Bone parameters of elite athletes with oligomenorrhea and prevalence seeking medical attention: a cross-sectional study. J Bone Miner Metab. 2021;39:1009–18.
pubmed: 34101019
doi: 10.1007/s00774-021-01234-1
Wakat DK, Sweeney KA, Rogol AD. Reproductive system function in women cross-country runners. Med Sci Sports Exerc. 1982;14:263–9.
pubmed: 7132642
doi: 10.1249/00005768-198204000-00002
Yamada K, Takeda T. Low Proportion of Dietary Plant Protein among Athletes with Premenstrual Syndrome-Related Performance Impairment. Tohoku J Exp Med. 2018;244:119–22.
pubmed: 29434077
doi: 10.1620/tjem.244.119
Feldmann JM, Belsha JP, Eissa MA, Middleman AB. Female adolescent athletes’ awareness of the connection between menstrual status and bone health. J Pediatr Adolesc Gynecol. 2011;24:311–4.
pubmed: 21872775
doi: 10.1016/j.jpag.2011.05.011
Muia EN, Wright HH, Onywera VO, Kuria EN. Adolescent elite Kenyan runners are at risk for energy deficiency, menstrual dysfunction and disordered eating. J Sports Sci. 2016;34:598–606.
pubmed: 26153433
doi: 10.1080/02640414.2015.1065340
Pavlak MJS. The inter-relatedness of nutrition, menstrual status, lean body mass, and injury among high school female varsity basketball players. Grand Valley State University; 1998. https://scholarworks.gvsu.edu/cgi/viewcontent.cgi?article=1388&context=theses . Accessed 6 Aug 2021.
Snyder AC, Wenderoth MP, Johnston CC, Hui SL. Bone mineral content of elite lightweight amenorrheic oarswomen. Hum Biol. 1986;58:863–9.
pubmed: 3557412
Takeda T, Imoto Y, Nagasawa H, Takeshita A, Shiina M. Fish consumption and premenstrual syndrome and dysphoric disorder in Japanese Collegiate Athletes. J Pediatr Adolesc Gynecol. 2016;29:386–9.
pubmed: 26836504
doi: 10.1016/j.jpag.2016.01.122
Takeda T, Yoshimi K, Imoto Y, Shiina M. Associations between sleep habits and interference of premenstrual symptoms in athletic performance in Japanese adolescent athletes: a cohort study over a 2-year period. Gynecol Endocrinol. 2020;36:885–9.
pubmed: 32124639
doi: 10.1080/09513590.2020.1734787
Vannuccini S, Fondelli F, Clemenza S, Galanti G, Petraglia F. Dysmenorrhea and heavy menstrual bleeding in elite female athletes: quality of life and perceived stress. Reprod Sci. 2020;27:888–94.
pubmed: 32046446
doi: 10.1007/s43032-019-00092-7
de Oliveira FP, Bosi MLM, dos Vigário PS, Vieira da RS. Comportamento alimentar e imagem corporal em atletas. Rev Bras Med Esporte. 2003;9:348–56.
doi: 10.1590/S1517-86922003000600002
O’Brien PMS, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14:13–21.
pubmed: 21225438
pmcid: 4134928
doi: 10.1007/s00737-010-0201-3
Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134–8.
pubmed: 16690671
pmcid: 1459624
doi: 10.1136/bmj.332.7550.1134
Armour M, Ee CC, Naidoo D, Ayati Z, Chalmers KJ, Steel KA, et al. Exercise for dysmenorrhoea. Cochrane Database oSyste Rev [Internet]. 2019. https://doi.org/10.1002/14651858.CD004142.pub4/full .
doi: 10.1002/14651858.CD004142.pub4/full
Casey ML, MacDonald PC, Mitchell MD. Despite a massive increase in cortisol secretion in women during parturition, there is an equally massive increase in prostaglandin synthesis. A paradox? J Clin Invest. 1985;75:1852–7.
pubmed: 3891787
pmcid: 425541
doi: 10.1172/JCI111899
Pascoe MC, Thompson DR, Ski CF. Yoga, mindfulness-based stress reduction and stress-related physiological measures: a meta-analysis. Psychoneuroendocrinology. 2017;86:152–68.
pubmed: 28963884
doi: 10.1016/j.psyneuen.2017.08.008
Bhatia SC, Bhatia SK. Diagnosis and treatment of premenstrual dysphoric disorder. AFP. 2002;66:1239.
McNamara A, Harris R, Minahan C. ‘That time of the month’… for the biggest event of your career! Perception of menstrual cycle on performance of Australian athletes training for the 2020 Olympic and Paralympic Games. BMJ Open Sport Exerc Med. 2022;8: e001300.
pubmed: 35505980
pmcid: 9014077
doi: 10.1136/bmjsem-2021-001300
Findlay R, Macrae E, Whyte I, Easton C, Forrest (née Whyte) L. How the menstrual cycle and menstruation affect sporting performance: experiences and perceptions of elite female rugby players. Br J Sports Med. 2020;54:1108–13.
Logue CM, Moos RH. Positive perimenstrual changes: Toward a new perspective on the menstrual cycle. J Psychosom Res. 1988;32:31–40.
pubmed: 3042993
doi: 10.1016/0022-3999(88)90086-4
Riaz Y, Parekh U. Oligomenorrhea [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Mar 15]. http://www.ncbi.nlm.nih.gov/books/NBK560575/ .
Nazem TG, Ackerman KE. The female athlete triad. sports. Health. 2012;4:302–11.
Mallinson R, Souza MJD. Current perspectives on the etiology and manifestation of the “silent” component of the Female Athlete Triad. Int J Women’s Health. 2014;6:451–67.
De Souza MJ. Menstrual disturbances in athletes: a focus on luteal phase defects. Med Sci Sports Exerc. 2003;35:1553–63.
pubmed: 12972877
doi: 10.1249/01.MSS.0000084530.31478.DF
Russell M, Misra M. Influence of ghrelin and adipocytokines on bone mineral density in adolescent female athletes with amenorrhea and eumenorrheic athletes. Med Sport Sci. 2010;55:103–13.
pubmed: 20956863
pmcid: 3663933
doi: 10.1159/000321975
Barrack MT, Gibbs JC, De Souza MJ, Williams NI, Nichols JF, Rauh MJ, et al. Higher incidence of bone stress injuries with increasing female athlete triad-related risk factors: a prospective multisite study of exercising girls and women. Am J Sports Med. 2014;42:949–58.
pubmed: 24567250
doi: 10.1177/0363546513520295
Vanheest JL, Rodgers CD, Mahoney CE, De Souza MJ. Ovarian suppression impairs sport performance in junior elite female swimmers. Med Sci Sports Exerc. 2014;46:156–66.
pubmed: 23846160
doi: 10.1249/MSS.0b013e3182a32b72
Mansour D, Hofmann A, Gemzell-Danielsson K. A Review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding. Adv Ther. 2021;38:201–25.
pubmed: 33247314
doi: 10.1007/s12325-020-01564-y
Hinton PS. Iron and the endurance athlete. Appl Physiol Nutr Metab. 2014;39:1012–8.
pubmed: 25017111
doi: 10.1139/apnm-2014-0147
Davies J, Kadir RA. Heavy menstrual bleeding: An update on management. Thromb Res. 2017;151:S70–7.
pubmed: 28262240
doi: 10.1016/S0049-3848(17)30072-5
Franchini E, Brito CJ, Artioli GG. Weight loss in combat sports: physiological, psychological and performance effects. J Int Soc Sports Nutr. 2012;9:52.
pubmed: 23237303
pmcid: 3607973
doi: 10.1186/1550-2783-9-52
Thomas S, Gonzalez A, Ghigiarelli J. The Relationship between weight cutting and the female athlete triad in combat sport athletes. Int J Kinesiol Sports Sci. 2021;9:9.
doi: 10.7575/aiac.ijkss.v.9n.1p.9
Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, et al. Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:1413–39.
pubmed: 28368518
doi: 10.1210/jc.2017-00131
Sharps FRJ, Wilson LJ, Graham CA-M, Curtis C. Prevalence of disordered eating, eating disorders and risk of low energy availability in professional, competitive and recreational female athletes based in the United Kingdom. Eur J Sport Sci. 2022;22:1445–51.
pubmed: 34121611
doi: 10.1080/17461391.2021.1943712
Meng K, Qiu J, Benardot D, Carr A, Yi L, Wang J, et al. The risk of low energy availability in Chinese elite and recreational female aesthetic sports athletes. J Int Soc Sports Nutr. 2020;17:13.
pubmed: 32131846
pmcid: 7055083
doi: 10.1186/s12970-020-00344-x
Loucks AB, Kiens B, Wright HH. Energy availability in athletes. J Sports Sci. 2011;29:S7-15.
pubmed: 21793767
doi: 10.1080/02640414.2011.588958
Kuikman MA, Mountjoy M, Burr JF. Examining the relationship between exercise dependence, disordered eating, and low energy availability. Nutrients. 2021;13:2601.
pubmed: 34444761
pmcid: 8398044
doi: 10.3390/nu13082601
Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism may explain reproductive dysfunction in olympic athletes. Med Sci Sports Exerc United States. 2009;41:1241–8.
doi: 10.1249/MSS.0b013e318195a21a
Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016;9:211–7.
pubmed: 27217764
pmcid: 4862344
doi: 10.2147/JMDH.S104807
Small CM, Manatunga AK, Marcus M. Validity of self-reported menstrual cycle length. Ann Epidemiol. 2007;17:163–70.
pubmed: 16882471
doi: 10.1016/j.annepidem.2006.05.005
Taffe J, Dennerstein L. Retrospective self-report compared with menstrual diary data prospectively kept during the menopausal transition. Climacteric. 2000;3:183–91.
pubmed: 11910620
doi: 10.1080/13697130008500099
National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. 2018. https://www.nice.org.uk/guidance/ng88 . Accessed 22 Mar 2022.
Zakherah MS, Sayed GH, El-Nashar SA, Shaaban MM. Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. GOI Karger Publishers. 2011;71:281–4.
Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734–9.
pubmed: 2400752
doi: 10.1111/j.1471-0528.1990.tb16249.x
Hald K, Lieng M. Assessment of Periodic Blood Loss: Interindividual and Intraindividual Variations of Pictorial Blood Loss Assessment Chart Registrations. J Minim Invasive Gynecol. 2014;21:662–8.
pubmed: 24469275
doi: 10.1016/j.jmig.2014.01.015
Herman MC, Mol BW, Bongers MY. Diagnosis of heavy menstrual bleeding. Womens Health (Lond Engl). 2016;12:15–20.
pubmed: 26696006
doi: 10.2217/whe.15.90
Magnay JL, O’Brien S, Gerlinger C, Seitz C. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20:24.
pubmed: 32041594
pmcid: 7011238
doi: 10.1186/s12905-020-0887-y
Sokol ER, Casele H, Haney EI. Ultrasound examination of the postpartum uterus: what is normal? J Matern Fetal Neonatal Med. 2004;15:95–9.
pubmed: 15209115
doi: 10.1080/14767050310001650798
Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. AFP. 2016;94:236–40.
Diaz A, Laufer MR, Breech LL, American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006;118:2245–50.
pubmed: 17079600
doi: 10.1542/peds.2006-2481
Jamieson MA. Disorders of Menstruation in Adolescent Girls. Pediatr Clin N Am. 2015;62:943–61.
doi: 10.1016/j.pcl.2015.04.007
American College of Obstetricians and Gynecologists. Practice Bulletin No. 136: Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction. 2013. https://journals.lww.com/greenjournal/Citation/2013/07000/Practice_Bulletin_No__136__Management_of_Abnormal.38.aspx . Accessed 1 Nov 2021.
Armour M, Dahlen HG, Smith CA. More than needles: the importance of explanations and self-care advice in treating primary dysmenorrhea with acupuncture. Evid Based Complement Altern Med. 2016;2016:3467067.
doi: 10.1155/2016/3467067
As-Sanie S, Black R, Giudice LC, Gray Valbrun T, Gupta J, Jones B, et al. Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol. 2019;221:86–94.
pubmed: 30790565
doi: 10.1016/j.ajog.2019.02.033
Hudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D, et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod. 2012;27:3412–6.
pubmed: 22990516
doi: 10.1093/humrep/des316
Ramos-Pichardo JD, Ortega-Galán ÁM, Iglesias-López MT, Abreu-Sánchez A, Fernández-Martínez E. Why do some spanish nursing students with menstrual pain fail to consult healthcare professionals? Int J Environ Res Public Health. 2020;17:8173.
pubmed: 33167417
pmcid: 7663954
doi: 10.3390/ijerph17218173
Frankovich RJ, Lebrun CM. Menstrual cycle, contraception, and performance. Clin Sports Med. 2000;19:251–71.
pubmed: 10740758
doi: 10.1016/S0278-5919(05)70202-7
Lethaby A, Wise MR, Weterings MA, Rodriguez MB, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev [Internet]. 2019. https://doi.org/10.1002/14651858.CD000154.pub3/full .
doi: 10.1002/14651858.CD000154.pub3/full
pubmed: 31535715
Davis AR, Westhoff C, O’Connell K, Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol. 2005;106:97–104.
pubmed: 15994623
doi: 10.1097/01.AOG.0000165826.03915.65